Patent Assignment
Reel/Frame 045452/0543
Assignment of Assignor's Interest
Recorded: 2018-04-05
Pages: 5
Assignee
CELGENE CORPORATION
86 MORRIS AVENUE, SUMMIT, NEW JERSEY, 07901
Covered Property
(1)
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Patent:
10,328,077 →
Application:
15/673,084 →
Publication:
US 2018/0125844
PCT:
PCT/US2017/046098 ↗
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 19, 2018
From: QUANTICEL PHARMACEUTICALS, INC.
To: CELGENE CORPORATION
Reel/Frame 046912/0972 →
Employment Agreement
Sep 19, 2018
From: CHO, ROBERT
To: QUANTICEL PHARMACEUTICALS, INC
Reel/Frame 047321/0235 →
Assignment of Assignor's Interest
Nov 11, 2019
From: CELGENE CORPORATION
To: CELGENE QUANTICEL RESEARCH, INC.
Reel/Frame 050974/0894 →